3971-29-7Relevant articles and documents
Novel bridged tetradentate fourth subgroup metal complex as well as preparation method and application thereof (by machine translation)
-
Paragraph 0223-0227, (2020/10/14)
The invention provides a novel bridged tetradentate fourth subgroup metal complex and a preparation method and application thereof, wherein the complex has a formula a structure, the temperature tolerance is good, and the complex can maintain very high catalytic activity under 120 °C, can obtain ultrahigh molecular weight polyethylene, and can catalyze ethylene and norbornene, 1 - hexene and 1 - octene copolymerization reaction to obtain a polymer product with high comonomer insertion rate. (by machine translation)
ZINC COMPLEX
-
Paragraph 0160-0161, (2016/05/19)
A zinc complex characterized in exhibiting an octahedral structure and being configured from repeating units represented by general formula (I): wherein L represents a linker region, and R1 represents a C1-4 alkyl group, which can have a halogen atom.
1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide: An effective scaffold for the design of either CB1 or CB2 receptor ligands
Piscitelli, Francesco,Ligresti, Alessia,La Regina, Giuseppe,Gatti, Valerio,Brizzi, Antonella,Pasquini, Serena,Allar, Marco,Carai, Mauro Antonio Maria,Novellino, Ettore,Colombo, Giancarlo,Di Marzo, Vincenzo,Corelli, Federico,Silvestri, Romano
experimental part, p. 5641 - 5653 (2012/01/02)
New 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides were synthesized as cannabinoid (CB) receptor ligands. Compound 11 (CB1 Ki = 2.3 nM, CB1 SI = 163.6) showed CB1 receptor affinity and selectivity superior to Rimonabant and AM251. Acute administration of 2 mg/kg 11 reduced sucrose, but not regular food, intake in rats. On the other hand, compound 23 (CB2 Ki = 0.51 nM, CB2 SI = 30.0) showed significant affinity and selectivity for the CB2 receptor. The results presented here show that the 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3- carboxamide may serve as an effective scaffold for the design of either CB 1 or CB2 receptor ligands.